BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31637884)

  • 1. An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast.
    Kim S; Kim J; Park HS; Kim HY; Lee K; Lee J; Lee H; Kim JY; Kim SI; Cho YU; Park BW
    Yonsei Med J; 2019 Nov; 60(11):1028-1035. PubMed ID: 31637884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
    Jakub JW; Murphy BL; Gonzalez AB; Conners AL; Henrichsen TL; Maimone S; Keeney MG; McLaughlin SA; Pockaj BA; Chen B; Musonza T; Harmsen WS; Boughey JC; Hieken TJ; Habermann EB; Shah HN; Degnim AC
    Ann Surg Oncol; 2017 Oct; 24(10):2915-2924. PubMed ID: 28766196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
    Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
    Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
    Kondo T; Hayashi N; Ohde S; Suzuki K; Yoshida A; Yagata H; Niikura N; Iwamoto T; Kida K; Murai M; Takahashi Y; Tsunoda H; Nakamura S; Yamauchi H
    J Surg Oncol; 2015 Oct; 112(5):476-80. PubMed ID: 26346047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy.
    Park HS; Kim HY; Park S; Kim EK; Kim SI; Park BW
    Breast; 2013 Oct; 22(5):869-73. PubMed ID: 23601760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
    Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
    World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ.
    Munck F; Clausen EW; Balslev E; Kroman N; Tvedskov TF; Holm-Rasmussen EV
    Br J Surg; 2020 Jan; 107(1):96-102. PubMed ID: 31823362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Nomograms Useful in Predicting Upstage From Ductal Carcinoma In Situ to Invasive Carcinoma Requiring Sentinel Lymph Node Biopsy?
    Kapadia S; Lee A; Kaji AH; Ozao-Choy J; Dauphine C
    Am Surg; 2020 Oct; 86(10):1238-1242. PubMed ID: 33135939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!
    Marques LC; Marta GN; de Andrade JZ; Andrade D; de Barros ACSD; Andrade FEM
    Eur J Surg Oncol; 2019 Jul; 45(7):1152-1155. PubMed ID: 30665684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI-Based Radiomics.
    Hong M; Fan S; Yu Z; Gao C; Fang Z; Du L; Wang S; Chen X; Xu M; Zhou C
    J Magn Reson Imaging; 2023 Aug; 58(2):454-463. PubMed ID: 36440711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
    Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
    Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
    Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
    Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep-learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy.
    Huang CY; Chang RF; Lin CY; Hsieh MS; Liao PC; Wang YJ; Kao YC; Porta L; Lin PY; Lee CC; Lee YH
    Histopathology; 2024 May; 84(6):983-1002. PubMed ID: 38288642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
    Park AY; Gweon HM; Son EJ; Yoo M; Kim JA; Youk JH
    Eur J Radiol; 2014 Apr; 83(4):654-9. PubMed ID: 24534119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
    Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
    J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
    Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
    J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
    Yoo J; Kim BS; Yoon HJ
    Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
    Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
    Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ.
    Mori K; Takeda M; Kodama Y; Kiyokawa H; Yasojima H; Mizutani M; Otani Y; Morikawa N; Masuda N; Mano M
    Hum Pathol; 2017 Jun; 64():145-155. PubMed ID: 28434924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.